Serum lipids, blood pressure and body weight around the age of the menopause

European Journal of Preventive Cardiology

Volumn 15, Issue 1, 2008, Pages 83-88

  Graff Iversen, Sidsel ^a   Thelle, Dag S ^b   Hammar, Niklas ^c  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

blood pressure; body mass index; menopause; serum lipids

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HORMONAL THERAPY; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; STRUCTURED INTERVIEW;

ADULT; BLOOD PRESSURE DETERMINATION; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL; COHORT STUDIES; FEMALE; HUMANS; LIPIDS; MENOPAUSE; MIDDLE AGED; NORWAY; TRIGLYCERIDES;

EID: 39349092588     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3282f0e357     Document Type: Article

References (29)

1. Schubert CM, Rogers NL, Remsberg KE, Sun SS, Chumlea WC, Demerath EW, et al. Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age: the Fels longitudinal study. Int J Obes 2006; 30: 252–260.
2. Guthrie JR, Dennestein L, Taffe JR, Lehert P, Burger HG. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric 2004; 7: 375–389.
3. Zanchetti A, Facchetti R, Cesana GC, Modena MG, Pirrelli A, Sega R; SIMONA participants. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens 2005; 23: 2269–2276.
4. Izumi S, Muano T, Mori A, Kika G, Okuwaki S. Common carotid artery stiffness, cardiovascular function and lipid metabolism after menopause. Life Sciences 2006; 78: 1696–1701.
5. Mack WJ, Slater CC, Xian M, Shoupe D, Lobo RA, Hodis HN. Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause. Fertil Steril 2004; 82: 391–397.
6. Writing group for the PEPI trial. Effects of oestrogen or progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 1995; 273: 199–208.
7. Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C etal.; Women's Health Initiative Investigators. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 2004; 47: 1175–1187.
8. Jacobsen BK, Heuch I, Kvåle G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19731 Norwegian women. Am J Epidemiol 2003; 157: 923–929.
9. Mondul AM, Rodrigues C, Jacobs EJ, Calle EE. Age at natural menopause and cause-specific mortality. Am J Epidemiol 2005; 162: 1089–1097.
10. Hu FB, Grodstein F, Hennekens CH, Colditz GA, Johnson M, Manson JE, et al. Age at natural menopause and risk of cardiovascular disease. Arch Int Med 1999; 159: 1061–1066.
11. Lawlor DA, Ebrahim S, Davey Smith G. Role of endogenous oestrogen in aetiology of coronary heart disease: analysis of age related trends in coronary heart disease and breast cancer in England and Wales and Japan. BMJ 2002; 325: 311–312.
12. Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR, et al. Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 2003; 349: 535–545.
13. Do KA, Green A, Guthrie JR, Dudley EC, Burger GH, Dennerstein L. Longitudinal study of risk factors for coronary heart disease across the menopausal transition. Am J Epidemiol 2000; 151: 584–593.
14. Kim CJ, Kim TH, Ryu WS, Ryoo UH. Influence of menopause on high density lipoprotein-cholesterol and lipids. J Korean Med Sci 2000; 15: 380–386.
15. Blumel JE, Castelo-Branco C, Rocangliolo ME, Bifa L, Tacla X, Mamani L. Changes in body mass index around menopause: a population study of Chilean women. Menopause 2001; 8: 230–232.
16. Donato GB, Fuchs SC, Oppermann K, Bastos C, Spritzer PM. Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause 2006; 13: 280–285.
17. Rønning M, editor. Drug consumption in Norway 1998–2002. Oslo: Norwegian Institute of Public Health; 2003.
18. Bjartveit K, Foss PO, Gjervig T, Lund-Larsen PG. The cardiovascular disease study in Norwegian counties. Background and organization. Acta Med Scand Suppl 1979; 634: 1–70.
19. Wilhelmsen L, Tibblin G, Aurell M, Bjure J, Ekström-Jodal B, Grimby G. Physical activity, physical fitness and risk of myocardial infarction. Adv Cardiol 1976; 18: 217–230.
20. Lund-Larsen PG. Blood pressure measured with a sphygmomanometer and with DINAMAP under field conditions: a comparison. Nor Epidemiol 1997; 7: 235–241.
21. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham study. Am Heart J 1987; 114: 413–419.
22. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med 1989; 321: 641–646.
23. Berg GA, Siseles N, Gonzales AI, Ortiz OC, Tempone A, Wikinski RW. Higher values of hepatic lipase activity in postmenopause: relationship with atherogenic intermediate density and low density lipoproteins. Menopause 2001; 8: 51–57.
24. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. On behalf of the SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.
25. Hammar N, Alfredsson L, Rosén M, Spetz CL, Kahan T, Ysberg AS. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol 2001; 30: S30–S34.
26. Santoro N. Mechanisms of premature ovarian failure. Ann Endocrinol 2003; 64: 87–92.
27. Hardy R, Kuh D. Does early growth influence timing of the menopause? Evidence from a British birth cohort. Hum Reprod 2002; 17: 2474–2479.
28. Wise LA, Krieger N, Zierler S, Harlow BL. Lifetime socioeconomic position in relation to onset of perimenopause. J Epidemiol Community Health 2002; 56: 815–860.
29. Moen M. Differences in the practice of hysterectomy. Tidsskr Nor Laegeforen 2004; 124: 767.